Skye Bioscience 관리
관리 기준 확인 2/4
Skye Bioscience's CEO is Punit Dhillon, appointed in Aug 2020, has a tenure of 4.25 years. total yearly compensation is $1.81M, comprised of 24.9% salary and 75.1% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth $244.81K. The average tenure of the management team and the board of directors is 2.5 years and 0.7 years respectively.
주요 정보
Punit Dhillon
최고 경영자
US$1.8m
총 보상
CEO 급여 비율 | 24.9% |
CEO 임기 | 4.3yrs |
CEO 소유권 | 0.1% |
경영진 평균 재임 기간 | 2.5yrs |
이사회 평균 재임 기간 | less than a year |
CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$42m |
Mar 31 2024 | n/a | n/a | -US$37m |
Dec 31 2023 | US$2m | US$450k | -US$38m |
Sep 30 2023 | n/a | n/a | -US$43m |
Jun 30 2023 | n/a | n/a | -US$21m |
Mar 31 2023 | n/a | n/a | -US$22m |
Dec 31 2022 | US$668k | US$433k | -US$19m |
Sep 30 2022 | n/a | n/a | -US$12m |
Jun 30 2022 | n/a | n/a | -US$11m |
Mar 31 2022 | n/a | n/a | -US$9m |
Dec 31 2021 | US$900k | US$400k | -US$9m |
Sep 30 2021 | n/a | n/a | -US$8m |
Jun 30 2021 | n/a | n/a | -US$7m |
Mar 31 2021 | n/a | n/a | -US$6m |
Dec 31 2020 | US$615k | US$160k | -US$7m |
Sep 30 2020 | n/a | n/a | -US$207k |
Jun 30 2020 | n/a | n/a | -US$4m |
Mar 31 2020 | n/a | n/a | US$13m |
Dec 31 2019 | US$65k | n/a | US$1m |
Sep 30 2019 | n/a | n/a | -US$10m |
Jun 30 2019 | n/a | n/a | -US$7m |
Mar 31 2019 | n/a | n/a | -US$26m |
Dec 31 2018 | US$82k | n/a | -US$19m |
보상 대 시장: Punit's total compensation ($USD1.81M) is about average for companies of similar size in the US market ($USD1.48M).
보상과 수익: Punit's compensation has increased whilst the company is unprofitable.
CEO
Punit Dhillon (44 yo)
4.3yrs
테뉴어
US$1,807,338
보상
Mr. Punit S. Dhillon, BA, has been Chief Executive Officer of Skye Bioscience, Inc. since August 10, 2020. Mr. Dhillon serves as Chair of Skye Bioscience, Inc. until October 25, 2024. He served as Principa...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
President | 4.3yrs | US$1.81m | 0.15% $ 244.8k | |
Chief Financial Officer | 3.1yrs | US$1.27m | 0.13% $ 220.4k | |
Chief Scientific Officer | 1.9yrs | 데이터 없음 | 데이터 없음 | |
Chief Development Officer | no data | 데이터 없음 | 0.0088% $ 14.8k | |
Chief Medical Officer | less than a year | 데이터 없음 | 데이터 없음 |
2.5yrs
평균 재임 기간
43.5yo
평균 연령
경험이 풍부한 관리: SKYE's management team is considered experienced (2.5 years average tenure).
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
President | 6.8yrs | US$1.81m | 0.15% $ 244.8k | |
Independent Chairman of the Board | 1.3yrs | US$1.25m | 0.077% $ 129.7k | |
Director | 1.3yrs | US$74.08k | 0% $ 0 | |
Member of Clinical & Scientific Advisory Board | less than a year | 데이터 없음 | 데이터 없음 | |
Independent Director | less than a year | 데이터 없음 | 0% $ 0 | |
Director | less than a year | 데이터 없음 | 0% $ 0 | |
Independent Director | 1.8yrs | US$102.28k | 0% $ 0 | |
Member of Clinical & Scientific Advisory Board | less than a year | 데이터 없음 | 데이터 없음 | |
Member of Clinical & Scientific Advisory Board | less than a year | 데이터 없음 | 데이터 없음 | |
Member of Clinical & Scientific Advisory Board | less than a year | 데이터 없음 | 데이터 없음 | |
Member of Clinical & Scientific Advisory Board | less than a year | 데이터 없음 | 데이터 없음 |
0.7yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: SKYE's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.